Mednax Inc (MD) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.

Total Cash From Operating Activities Chart for Mednax Inc

Mednax Inc (MD) operating cash flow for FY2025 was USD 271.1M, a 31.2% change from FY2024. Mednax Inc's operating cash flow grew from USD 5.4M in 1994 to USD 271.1M in 2025 (4920.2% over 31 years). Operating cash flow compound annual growth rate: 5-year CAGR of 5.8%, 10-year CAGR of -3.0%, 20-year CAGR of 2.6%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$2.38B
Implied Share Price
$29.29
Enterprise Value
$2.36B
Revenue (TTM)
$1.95B
EBITDA
$263.74M
Profit Margin
8.96%
Trailing P/E
13.31
Forward P/E
9.29
Price/Book (MRQ)
2.43
Price/Sales (TTM)
1.22
EV/EBITDA
8.32
EV/Revenue
1.21
Dividend Yield
—
Book Value
$11.11
Free Cash Flow (FY2025)
$252.63M
Free Cash Flow Yield
10.62%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.